Treatment of superior vena cava thrombosis with recombinant tissue type plasminogen activator.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1902161.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thrombotic occlusion of the superior vena cava is an uncommon but serious complication of chronic indwelling venous catheters. Several reports have shown thrombolytic therapy with intravenous streptokinase or urokinase to be effective in the treatment of this condition. We report a case of superior vena cava thrombosis in a 53-year-old woman receiving chemotherapy for breast carcinoma through a subcutaneously implanted venous access catheter who was successfully treated with peripheral infusion of recombinant tissue type plasminogen activator (rtPA).
Medical subject headings
- Superior Vena Cava Syndrome
- Thrombolytic Therapy
- Tissue Plasminogen Activator